Local News: Los Angeles, CA 

 | 

Sign Up

 | 

Sign In

Advertisment

Levaquin, Levofloxacin Wire (Page 2)

Comprehensive News Feed for Levaquin, Levofloxacin (generic).

Results 21 - 39 of 39 in Levaquin, Levofloxacin (generic)

  1. FDA Approves New Indication For Wyeth's TYGACIL (tigecycline)...Read the original story

    Mar 26, 2009 | Pharmaceutical Online

    March 26, 2009 Wyeth Pharmaceuticals, a division of Wyeth , announced recently that the U.S. Food and Drug Administration approved TYGACIL , for the treatment of adult patients with community-acquired bacterial pneumonia caused by susceptible strains of indicated pathogens.

    Comment?

    Related Topix: Food and Drug Administration, Biotech, Medicine, Healthcare Industry, Pneumonia, Health, Medication

  2. Novexel Strengthens its Scientific Advisory Board With the Appointment of Dr. Karen BushRead the original story

    Mar 26, 2009 | PR Newswire

    Karen Bush to the Company's Scientific Advisory Board . Novexel's SAB is chaired by Dr.

    Comment?

    Related Topix: Biology, Science, Microbiology

  3. Company and People Notes: Daiichi Sankyo Sues 13 Generic Drugmakers; Ischemix Appoints CEO; More...

    Mar 25, 2009 | Pharmaceutical Technology

    Daiichi Sankyo is suing 13 generic-drug companies for the substance patent and usage patent for Cravit tablets and fine granules , according to a company press release.

    Comment?

    Related Topix: Medicine, Medication, Biotech, Food and Drug Administration, Teva Pharmaceutical Industries, US Politics, US News, US House of Representatives, Henry Waxman, Democrat

  4. Drug-resistance in Streptococcus pneumoniae isolates among Spanish...

    Mar 25, 2009 | BMC Infectious Diseases

    Pneumococcal diseases remain a major cause of morbidity and mortality worldwide.

    Comment?

    Related Topix: Medicine, Erythromycin (generic), E-Base, E-Mycin, Medication

  5. FDA Approves New Indication For Wyeth's TYGACIL (tigecycline) For The ...Read the original story

    Mar 25, 2009 | Medical News Today

    Main Category: Infectious Diseases / Bacteria / Viruses Also Included In: Respiratory / Asthma ; Regulatory Affairs / Drug Approvals ; Clinical Trials / Drug Trials Article Date: 25 Mar 2009 - 1:00 PDT Wyeth Pharmaceuticals, a division of Wyeth , announced that the U.S. Food and Drug Administration approved TYGACIL , for the treatment of adult ...

    Comment?

    Related Topix: Food and Drug Administration, Wyeth, Biotech, Medicine, Healthcare Industry, Pneumonia, Health, Medication

  6. FDA approves new indication for Wyeth's TygacilRead the original story

    Mar 24, 2009 | News-Medical.Net

    Wyeth Pharmaceuticals, a division of Wyeth has announced that the U.S. Food and Drug Administration approved Tygacil , for the treatment of adult patients with community-acquired bacterial pneumonia caused by susceptible strains of indicated pathogens.

    Comment?

    Related Topix: Food and Drug Administration, Biotech, Medicine, Healthcare Industry, Pneumonia, Health, Medication

  7. Daiichi Sankyo Files Patent Infringement Actions Against 13 Generics...

    Mar 24, 2009 | Med Ad News

    TOKYO, March 23, 2009 Daiichi Sankyo Company, Limited announced that it has brought patent infringement litigation against 13 generics companies for the substance patent and usage patent for Levofloxacin Hydrate* . Levofloxacin Hydrate broad-spectrum oral anti-bacterial agents originated by Daiichi Sankyo, has been marketed by the company in Japan ...

    Comment?

    Related Topix: Medicine, Medication

  8. Cumulative H. pylori eradication rates in clinical practiceRead the original story

    Mar 18, 2009 | GastroHep.com News

    A recent study in the American College of Gastroenterology examines the cumulative H. pylori eradication rates in clinical practice by adopting regimens proposed by the Maastricht III consensus.

    Comment?

    Related Topix: Gastroenterology, Medicine, Helicobacter Pylori, Health, Amoxicillin (generic), Amoxil, Trimox

  9. Drug News: Fluoroquinolone-induced tendinopathy

    Feb 19, 2009 | Nursing Center

    DRUG NEWS: Fluoroquinolone-induced tendinopathy On July 8, 2008, the FDA requested that the different manufacturers of fluoroquinolone antibiotics strengthen the warnings section in their prescribing ...

    Comment?

    Related Topix: Medicine, NegGram, Nalidixic Acid (generic), Medication, Urinary Tract Infections, Health, Cipro, Ciprofloxacin (generic), Floxin, Ofloxacin (generic), Noroxin, Norfloxacin (generic)

  10. Pharmacodynamic modeling of aminoglycosides against Pseudomonas...

    Feb 16, 2009 | CiteULike

    Abstract To facilitate optimal dosing regimen design, we previously developed a mathematical model using time-kill study data to predict the responses of Pseudomonas aeruginosa to various pharmacokinetic ...

    Comment?

    Related Topix: Medicine, Medication

  11. San Diego--- Mpex Pharmaceuticals Announces Series D Financing of Up to $40 MillionRead the original story

    Feb 10, 2009 | Freshnews

    Mpex Pharmaceuticals, Inc. today announced that it has completed a $27.5 million initial closing of a Series D financing led by Investor Growth Capital.

    Comment?

    Related Topix: Venture Capital, Emerging Technology, Medicine, Medication, Food and Drug Administration

  12. Mpex Pharmaceuticals, Inc. Announces Series D Financing of Up to $40 Million

    Feb 10, 2009 | BioSpace

    Mpex Pharmaceuticals, Inc. today announced that it has completed a $27.5 million initial closing of a Series D financing led by Investor Growth Capital.

    Comment?

    Related Topix: Venture Capital, Emerging Technology, Medicine, Medication, Food and Drug Administration

  13. Pharmaceuticals Sold In Sweden Cause Serious Environmental Harm In India, Research ShowsRead the original story

    Feb 6, 2009 | Science Daily

    Some of these factories release large quantities of antibiotics and other pharmaceutical substances into the environment.

    Comment?

    Related Topix: Gothenburg, Sweden, Sweden, World News, India, Hyderabad, India, Andhra Pradesh, India

  14. Pharmaceuticals Sold In Sweden Cause Serious Environmental Harm In IndiaRead the original story

    Feb 6, 2009 | MediLexicon

    Infectious Diseases / Bacteria / Viruses Water - Air Quality / Agriculture Article Date: 06 Feb 2009 Many of the substances in our most common medicines are manufactured in India and China.

    Comment?

    Related Topix: Gothenburg, Sweden, Sweden, World News, India, Hyderabad, India, Andhra Pradesh, India, Health

  15. The Mulligan Law Firm Is Now Evaluating Potential Cipro, Levaquin,...Read the original story

    Feb 6, 2009 | PRWeb

    Fluoroquinolones are drugs that actively kill bacteria. Cipro falls into this specific category. 1 comment

    Related Topix: Medicine, Cipro, Ciprofloxacin (generic), Medication, Dallas, TX

  16. Rib-X Pharmaceuticals, Inc. Raises $25 Million

    Feb 5, 2009 | BioSpace

    Rib-X Pharmaceuticals, Inc. , a development-stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic-resistant infections, today announced positive final ...

    Comment?

    Related Topix: Healthcare Law, Law, Venture Capital, Emerging Technology, Biotech, Medicine, Healthcare Industry, Food and Drug Administration, MRSA, Health, Medication

  17. Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for...Read the original story

    Jan 26, 2009 | Drugs.com

    Rib-X Pharmaceuticals, Inc. , a development-stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic-resistant infections, today announced positive final ...

    Comment?

    Related Topix: Healthcare Law, Law, Venture Capital, Emerging Technology, Biotech, Medicine, Healthcare Industry, Food and Drug Administration, MRSA, Health, Medication

  18. TaiGen Biotechnology Secures $37 Million USD in Series C Round FinancingRead the original story

    Jan 20, 2009 | BioSpace

    TaiGen Biotechnology Co., Ltd., a privately-held pharmaceutical company focused on developing drugs to treat infectious diseases, cancer and diabetes-related complications, announced that it has raised 37 ...

    Comment?

    Related Topix: Medicine, Diabetes, Health, Stem Cell Research, Science / Technology

  19. TaiGen Biotechnology Secures 37 Million USD in Series C Round FinancingRead the original story

    Jan 20, 2009 | Quamnet

    20 /PRNewswire-Asia/ -- TaiGen Biotechnology Co., Ltd., a privately-held pharmaceutical company focused on developing drugs to treat infectious diseases, cancer and diabetes-related complications, announced ...

    Comment?

    Related Topix: Taipei, Taiwan, Taiwan, Medicine, Diabetes, Health, Stem Cell Research, Science / Technology